Details
Hits: 675

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

cover biotech acta general

Biotechnologia Acta V. 18, No. 6, 2025
P. 5-12, Bibliography 26, Engl.
UDC:  615.371:159.944.4
doi: https://doi.org/10.15407/biotech18.06.005

Full text: (PDF, in English)

PHARMACOLOGICAL ASPECTS OF BIOLOGICAL DRUGS FOR POSTTRAUMATIC STRESS DISORDER

LYPEY І.M., BOYKO N.V.

Uzhhorod National University, Ukraine

Aim. To analyze the pharmacodynamic and pharmacokinetic features of the latest biologics for the correction of posttraumatic stress disorder, and to assess their therapeutic potential for personalized medicine.

Мethods. The study employs general scientific approaches, including analysis, synthesis, and abstraction of scientific papers related to neurobiology, psychopharmacology, and microbiology, which were identified through an Internet search using the electronic databases Web of Science, Scopus, PubMed, and Google Scholar.

Results. PTSD is associated with dysregulation of neurotransmitter systems, hyperactivity of the amygdala, reduced activity of the prefrontal cortex, and disorders of the gut-brain axis. The latest biologics, such as BNC210, which modulates the cholinergic system, and probiotics (Lactobacillus, Bifidobacterium), which affect the microbiome, demonstrate high efficacy. Biologics have a rapid onset of action (6–8 weeks for probiotics) and minimal side effects. However, high cost and limited clinical trial data are significant barriers.

Conclusions. Biologics offer new perspectives for the treatment of PTSD due to their unique mechanisms of action and safety. Their potential in personalized medicine, in particular through modulation of the individual microbiome, is promising. Further research and optimization of dosage will facilitate the integration of biologics into standard treatment protocols, improving treatment efficacy and quality of life for patients.

Keywords: posttraumatic stress disorder, biologics, pharmacodynamics, pharmacokinetics, neuro biology, personalized medicine, microbiome, therapeutic potential.

© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2025

{accordion title="References" open="false"}

  1. Ishchuk, O. V. (2016). Post-Traumatic stress disorder (PTSD) in military veterans: understanding Ukrainian context. Problemy suchasnoi psykholohii. 2(10), 55–57. https://doi.org/10.33989/2226-4078.2023.2.288310
  2. Iribarren J., Prolo P., Neagos N. (2005). Posttraumatic stress disorder: evidence-based research for the third millennium. Evid Based Complement Alternat Med., 2(4), 503–512. https://doi.org/10.1093/ecam/neh127
  3. Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Posttraumatic Stress Disorder (PTSD). (2023). URL: https://www.globenewswire.com/news-release/2023/09/28/2751004/0/en/Bionomics-Announces-Positive-Topline-Results-from-the-Phase-2b-ATTUNE-Clinical-Trial-of-BNC210-in-Patients-with-Posttraumatic-Stress-Disorder-PTSD.html
  4. Pinto-Sanchez M. I., Hall G. B., Ghajar K., Nardelli, A., Bolino, C., Lau, J.T., Martin, F-P., Cominetti, O.,…, Bercik, P. (2017). Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology, 153(2), 448–459.e8. https://doi.org/10.1053/j.gastro.2017.05.003
  5. Unified clinical protocol of primary and specialized medical care. Acute stress reaction. Post-traumatic stress disorder. Adjustment disorder. (2024). Ministry of Health of Ukraine. URL: https://moz.gov.ua/storage/uploads/ec4ae01d-d0d3-4c0a-bf92-3cefbef633be/dn_1265_19072024_dod.pdf
  6. Demirci Ö., Erbaş O. (2024). Neurobiological Insights into Posttraumatic Stress Disorder. Journal of Experimental and Basic Medical Sciences, 5(3), 214–221. https://doi.org/10.5606/jebms.2024.1095
  7. Bakuridze N. H., Ovsiannikova Y. O., Kerdyvar V. V. (2024). Psychological support for the military: post-traumatic stress disorder and methods of overcoming it. Vcheni zapisky im V. I. Vernadskoho, Serhiya Psykhologiya, 35(74), 109–114. https://doi.org/10.32782/2709-3093/2024.2/18
  8. Pervanidou P., Chrousos G. P. (2010). Neuroendocrinology of Posttraumatic stress disorder. Progress in Brain Research, 182:149–160. https://doi.org/10.1016/S0079-6123(10)82005-9
  9. Dolynskyi P., Napryeyenko O. (2024). Cognitive impairment in victims of Russian aggression associated with Posttraumatic stress disorder (PTSD). Psychosomatic medicine and general practice, 9(3), https://doi.org/10.26766/pmgp.v9i4.568   
  10. Williamson, J. B., Porges, E. C., Lamb, D. G., Porges, S. W. (2015). Maladaptive autonomic regulation in PTSD accelerates physiological aging. Frontiers in Psychology, 5, 1571. https://doi.org/10.3389/fpsyg.2014.01571
  11. Sajeewane S. (2022). Pharmacotherapy for Posttraumatic Stress Disorder. Am Fam Physician, 106(6), 623–624. URL: https://www.aafp.org/pubs/afp/issues/2022/1200/cochrane-pharmacotherapy-ptsd.html
  12. Protasjuk L. (2024). Farmakoterapiya PTSR: shcho proponuyut biotekhnolohiyi? The Pharma Media, URL: https://thepharma.media/uk/medicine/35023-farmakoterapiya-ptsr-shho-proponuyut-biotexnologiyi-04062024
  13. Bionomics uspeshno vypytala preparat ot PTSR. The Pharma Media. 2023. URL: https://thepharma.media/uk/news/33212-bionomics-uspesno-ispytala-preparat-ot-ptsr-03102023
  14. Brenner, L. A., Stearns-Yoder, K. A., Stamper, C. E., Hoisington, A. J., Brostow, D. P., Hoffmire, C. A., Forster, J. E., Donovan, M. L., …, Lowry, C. A. (2022). Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD. Contemp Clin Trials Commun., 28, https://doi.org/10.1016/j.conctc.2022.100960
  15. Gholian, M. M., Babaei, A., Zendeboodi, F., Mortazavian, A. M., Koushki, V. (2024). Ameliorating effect of psychobiotics and para-psychobiotics on stress: A review on in vivo and clinical studies and mechanism of action. Heliyon, 10(22), https://doi.org/10.1016/j.heliyon.2024.e40338
  16. Du, Y., Gao, X.-R., Peng, L., Ge, J.-F. (2020). Crosstalk between the microbiota-gut-brain axis and depression. Heliyon, 6(6):e04097. https://doi.org/10.1016/j.heliyon.2020.e04097
  17. Wen, S., He, L., Zhong, Z., Zhao, R., Weng, S., Mi, H., Liu, F. (2021). Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis. Front Immunol., 12, https://doi.org/10.3389/fimmu.2021.741934
  18. Bharwani, A., Mian, M. F., Surette, M. G., Bienenstock, J., Forsythe, P. (2017). Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med., 15Ю, https://doi.org/10.1186/s12916-016-0771-7
  19. Lypey I. M., Yusko L. S., Boyko V. (2024). Innovative microbial-based therapies for Posttraumatic stress disorder. Biotechnologia Acta, 17(5), 14–23. https://doi.org/10.15407/biotech17.05.014
  20. Cryan J. F., Dinan T. G. (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci, 13(10):701–712. https://doi.org/10.1038/nrn3346
  21. Wang, J., Ji, H., Wang, S., Liu, H., Zhang, W., Zhang, D., Wang, Y. (2018). Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota. Front Microbiol., 9:1953. https://doi.org/10.3389/fmicb.2018.01953
  22. Eraly, S. A., Nievergelt, C. M., Maihofer, A. X., Barkauskas, D. A., Biswas, N., Agorastos, A., O’Connor, D. T., Baker, D. G. (2014). Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry, 71(4):423–431. https://doi.org/10.1001/jamapsychiatry.2013.4374
  23. Moya-Pérez A., Perez-Villalba A., Benítez-Páez A. (2017). Bifidobacterium CECT 7765 modulates early stress-induced immune, neuroendocrine and behavioral alterations in mice. Brain Behav Immun., 65:43–56. https://doi.org/10.1016/j.bbi.2017.05.011
  24. Kazemi A., Noorbala A. A., Azam K. (2019). Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr., 38(2):522–528. https://doi.org/10.1016/j.clnu.2018.04.010
  25. Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., Gil, A. (2015). The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int., 2015:505878. https://doi.org/10.1155/2015/505878
  26. Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., Tuohy, K. (2018). Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr., 57(1):1–24. https://doi.org/10.1007/s00394-017-1445-8

{/accordions}